Organization Profile

You just read:

Transition Therapeutics Announces ELND005 Presentations at the Clinical Trials in Alzheimer's Disease (CTAD) Meeting

News provided by

Transition Therapeutics Inc.

Nov 18, 2013, 06:31 ET